Match!
Amir Abbas Momtazi-Borojeni
Mashhad University of Medical Sciences
47Publications
9H-index
219Citations
Publications 47
Newest
Published on Mar 4, 2019in Artificial Cells Nanomedicine and Biotechnology4.46
Niloofar Farzad , Nastaran Barati6
Estimated H-index: 6
+ 10 AuthorsZahra Saberi4
Estimated H-index: 4
AbstractThe present study was aimed to develop an effective nanoliposomal vaccine delivery system with P435 HER2/neu-derived peptide conjugated to Maleimide-PEG2000-DSPE. The nanoliposome formulation composed of DSPC/DSPG/Chol/DOPE and monophosphoryl lipid A was used as an adjuvant. Liposomal formulations were prepared and their physical properties were characterized. Anti-tumoral efficacy of formulations was evaluated by immunization of tumor-bearing BALB/c mice and the generated immune respons...
Published on Dec 5, 2018in Journal of Biomolecular Structure & Dynamics3.31
Mahboubeh Hosseini-Kharat (IUST: Iran University of Science and Technology), Rahmatollah Rahimi17
Estimated H-index: 17
(IUST: Iran University of Science and Technology)
+ 6 AuthorsTecush Mohammadi4
Estimated H-index: 4
(IUT: Isfahan University of Technology)
Published in Iubmb Life3.05
Fataneh Tavasolian (TMU: Tarbiat Modares University), Ahmad Zavaran Hosseini9
Estimated H-index: 9
(TMU: Tarbiat Modares University)
+ -3 AuthorsThomas P. Johnston25
Estimated H-index: 25
(UMKC: University of Missouri–Kansas City)
Mahdi Hatamipour5
Estimated H-index: 5
(MUMS: Mashhad University of Medical Sciences),
Mahmoud Reza Jaafari31
Estimated H-index: 31
(MUMS: Mashhad University of Medical Sciences)
+ -3 AuthorsAmirhossein Sahebkar53
Estimated H-index: 53
(MUMS: Mashhad University of Medical Sciences)
Published on Aug 1, 2019in Journal of Cellular Physiology4.52
Amir Abbas Momtazi-Borojeni9
Estimated H-index: 9
(MUMS: Mashhad University of Medical Sciences),
Niki Katsiki31
Estimated H-index: 31
(A.U.Th.: Aristotle University of Thessaloniki)
+ 3 AuthorsAmirhossein Sahebkar53
Estimated H-index: 53
(MUMS: Mashhad University of Medical Sciences)
Published on Jul 5, 2019in Anti-cancer Agents in Medicinal Chemistry2.18
Mahdi Hatamipour5
Estimated H-index: 5
(MUMS: Mashhad University of Medical Sciences),
Mahmoud Reza Jaafari31
Estimated H-index: 31
(MUMS: Mashhad University of Medical Sciences)
+ 2 AuthorsAmirhossein Sahebkar53
Estimated H-index: 53
(MUMS: Mashhad University of Medical Sciences)
Amir Abbas Momtazi-Borojeni9
Estimated H-index: 9
(MUMS: Mashhad University of Medical Sciences),
Sarvenaz Sabouri-Rad2
Estimated H-index: 2
(MUMS: Mashhad University of Medical Sciences)
+ 5 AuthorsAmirhossein Sahebkar53
Estimated H-index: 53
(MUMS: Mashhad University of Medical Sciences)
Published on Jun 1, 2019in Atherosclerosis4.25
Abbas Shapouri Moghaddam1
Estimated H-index: 1
(MUMS: Mashhad University of Medical Sciences),
Jalil Tavakol Afshari9
Estimated H-index: 9
(MUMS: Mashhad University of Medical Sciences)
+ 3 AuthorsAmir Abbas Momtazi-Borojeni9
Estimated H-index: 9
(MUMS: Mashhad University of Medical Sciences)
Abstract The stem cell-based therapy has emerged as a promising therapeutic strategy for treating cardiovascular ischemic diseases (CVIDs), such as myocardial infarction (MI). However, some important functional shortcomings of stem cell transplantation, such as immune rejection, tumorigenicity and infusional toxicity, have overshadowed stem cell therapy in the setting of cardiovascular diseases (CVDs). Accumulating evidence suggests that the therapeutic effects of transplanted stem cells are pre...
123456